Keefe, Bruyette & Woods Issues Pessimistic Forecast for Crescent Capital BDC (NASDAQ:CCAP) Stock Price

Crescent Capital BDC (NASDAQ:CCAP) had its price target cut by research analysts at Keefe, Bruyette & Woods from $17.00 to $15.50 in a report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ price objective indicates a potential upside of 13.47% from the stock’s current price.

CCAP has been the topic of a number of other reports. Zacks Research cut shares of Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a research report on Wednesday, October 15th. LADENBURG THALM/SH SH upgraded shares of Crescent Capital BDC to a “strong-buy” rating in a report on Friday, August 15th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.38.

Crescent Capital BDC Price Performance

CCAP stock opened at $13.66 on Friday. The firm has a market cap of $505.32 million, a P/E ratio of 13.94 and a beta of 0.57. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.27 and a current ratio of 1.20. Crescent Capital BDC has a 1 year low of $13.30 and a 1 year high of $20.19. The stock has a 50-day simple moving average of $14.51 and a 200-day simple moving average of $14.83.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.01). Crescent Capital BDC had a return on equity of 9.76% and a net margin of 20.84%.The company had revenue of $41.35 million for the quarter, compared to analyst estimates of $42.35 million. On average, equities analysts predict that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Raymond Barrios bought 3,245 shares of the business’s stock in a transaction dated Monday, August 25th. The shares were acquired at an average price of $15.63 per share, for a total transaction of $50,719.35. Following the purchase, the director owned 19,177 shares in the company, valued at $299,736.51. This trade represents a 20.37% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.14% of the company’s stock.

Institutional Trading of Crescent Capital BDC

Several institutional investors and hedge funds have recently bought and sold shares of the company. Franklin Resources Inc. grew its position in shares of Crescent Capital BDC by 7.0% in the 3rd quarter. Franklin Resources Inc. now owns 540,460 shares of the company’s stock worth $7,707,000 after acquiring an additional 35,534 shares in the last quarter. Ares Management LLC lifted its stake in Crescent Capital BDC by 10.0% during the second quarter. Ares Management LLC now owns 516,409 shares of the company’s stock worth $7,281,000 after purchasing an additional 46,836 shares during the last quarter. North Ground Capital boosted its holdings in Crescent Capital BDC by 34.4% in the third quarter. North Ground Capital now owns 418,000 shares of the company’s stock worth $5,961,000 after purchasing an additional 107,000 shares during the period. Condor Capital Management increased its stake in Crescent Capital BDC by 6.2% during the third quarter. Condor Capital Management now owns 326,859 shares of the company’s stock valued at $4,661,000 after purchasing an additional 19,121 shares during the last quarter. Finally, Raymond James Financial Inc. raised its holdings in shares of Crescent Capital BDC by 16.5% during the third quarter. Raymond James Financial Inc. now owns 275,906 shares of the company’s stock worth $3,934,000 after purchasing an additional 39,089 shares during the period. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.